dasatinib
Showing 26 - 50 of 403
Prostate Cancer Trial (Dasatinib)
Withdrawn
- Prostate Cancer
- Dasatinib
- (no location specified)
Feb 23, 2022
Breast Tumors, Triple Negative Breast Tumors Trial in Chicago, Madison (drug, procedure, other)
Terminated
- Breast Neoplasms
- Triple Negative Breast Neoplasms
- Dasatinib
- +2 more
-
Chicago, Illinois
- +1 more
Jun 2, 2022
Leukemia, Lymphoblastic, Acute, Philadelphia-Positive Trial in Valencia (dasatinib)
Completed
- Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
- dasatinib
-
Valencia, SpainHospital La Fe
Mar 16, 2022
Malignant Pleural Mesothelioma Trial in Houston (Dasatinib)
Active, not recruiting
- Malignant Pleural Mesothelioma
- Dasatinib
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Feb 25, 2022
B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Recurrent B Acute
Recruiting
- B Acute Lymphoblastic Leukemia
- +2 more
- Dasatinib
- +4 more
-
Portland, OregonOHSU Knight Cancer Institute
Dec 16, 2022
Rhabdomyosarcoma, Rhabdomyosarcoma, Alveolar, Rhabdomyosarcoma, Embryonal Trial in Los Angeles, Bethesda (Dasatinib, Ganitumab)
Terminated
- Rhabdomyosarcoma
- +2 more
- Dasatinib
- Ganitumab
-
Los Angeles, California
- +1 more
Mar 17, 2022
Leukemia, Leukemia, Acute, Leukemia, Lymphoblastic Trial in Guangzhou (Chidamide, Dasatinib)
Recruiting
- Leukemia
- +3 more
- Chidamide
- Dasatinib
-
Guangzhou, Guangdong, ChinaDepartment of Hematology, Nanfang Hospital
Jun 28, 2022
Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer AJCC v6 and v7 Trial in
Active, not recruiting
- Metastatic Pancreatic Adenocarcinoma
- +3 more
- Dasatinib
- +2 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Dec 15, 2021
Multiple Indications Cancer Trial in France, Poland (Dasatinib)
Active, not recruiting
- Multiple Indications Cancer
- Dasatinib
-
Besancon, France
- +5 more
Dec 2, 2021
Breast Cancer, Bone Metastases Trial in Chicago, Durham, Houston (Dasatinib, Zoledronic Acid)
Completed
- Breast Cancer
- Bone Metastases
- Dasatinib
- Zoledronic Acid
-
Chicago, Illinois
- +2 more
Feb 2, 2022
Precursor Cell Lymphoblastic Leukemia-Lymphoma, Philadelphia-Positive Acute Lymphoblastic Leukemia, ALL, Adult Trial in Xi'an
Recruiting
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- +2 more
- dasatinib plus consolidation chemotherapy with vincristine and prednisone
- dasatinib plus consolidation chemotherapy with high-dose methotrexate and cytarabine
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xian Jiaotong University
Sep 29, 2021
Information of Ponatinib, Bosutinib, Imatinib, Dasatinib and
Completed
- Leukemia
- No Intervention
-
Cambridge, MassachusettsTakeda
Feb 28, 2023
Prostate Cancer Recurrent, Solid Tumor, Adult Trial in Charleston (Hydroxychloroquine, Metformin, Sirolimus, Hydroxychloroquine,
Recruiting
- Prostate Cancer Recurrent
- Solid Tumor, Adult
- Hydroxychloroquine, Metformin, Sirolimus
- +3 more
-
Charleston, South CarolinaMedical University of South Carolina
Apr 4, 2022
EGFR Gene Mutation, Nonsmall Cell Lung Cancer Trial in Washington, Hackensack (Dasatinib, Osimertinib)
Active, not recruiting
- EGFR Gene Mutation
- Nonsmall Cell Lung Cancer
- Dasatinib
- Osimertinib
-
Washington, District of Columbia
- +1 more
Jan 9, 2022
Mild Cognitive Impairment, Alzheimer Trial in Rochester (Dasatinib, Quercetin)
Enrolling by invitation
- Mild Cognitive Impairment
- Alzheimer Disease
- Dasatinib
- Quercetin
-
Rochester, MinnesotaMayo Clinic in Rochester
Jul 2, 2022
Chronic Myelogenous Leukemia Trial in Worldwide (Dasatinib)
Active, not recruiting
- Chronic Myelogenous Leukemia
- Dasatinib
-
Amman, Jordan
- +4 more
Jan 17, 2022
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid
Terminated
- Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
- +8 more
- cytarabine
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 28, 2022
Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic
Recruiting
- Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +2 more
- Laboratory Biomarker Analysis
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jun 15, 2022
Osteopenia, Osteoporosis Trial in Odense (Dasatinib 100 Mg Oral Tablet, Quercetin 1.250 mg (oral), Nicotinamide Riboside 1g
Recruiting
- Osteopenia, Osteoporosis
- Dasatinib 100 Mg Oral Tablet
- +2 more
-
Odense, DenmarkOdense University Hospital
Aug 29, 2023
Acute Lymphoblastic Leukemia Trial in Ann Arbor (Dasatinib, Ponatinib, Berlin-Frankfurt-Münster Chemotherapy)
Recruiting
- Acute Lymphoblastic Leukemia
- Dasatinib
- +3 more
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Nov 28, 2022
Aging Trial in Orlando (Dasatinib plus Quercetin)
Active, not recruiting
- Aging
- Dasatinib plus Quercetin
-
Orlando, FloridaThe Institute for Hormonal Balance
Aug 2, 2021
Prostate Cancer Trial in Houston (Abiraterone Acetate, Prednisone, Sunitinib)
Active, not recruiting
- Prostate Cancer
- Abiraterone Acetate
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 6, 2022
Alzheimer Trial in San Antonio (Dasatinib + Quercetin)
Active, not recruiting
- Alzheimer Disease
- Dasatinib + Quercetin
-
San Antonio, TexasGlenn Biggs Institute for Alzheimer's & Neurodegenerative Diseas
Jun 30, 2022
B-cell Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia (CML) in Lymphoid Blast Crisis, Philadelphia Chromosome Positive
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- +2 more
- ABL001
- +2 more
-
Chicago, Illinois
- +5 more
Dec 27, 2021